06.02.2013 Views

Monograph on the Potential Human Reproductive and ... - OEHHA

Monograph on the Potential Human Reproductive and ... - OEHHA

Monograph on the Potential Human Reproductive and ... - OEHHA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

parameters were examined at Day 30, 60, <strong>and</strong> 90 of <strong>the</strong><br />

study. Ophthalmoscopic examinati<strong>on</strong>s were c<strong>on</strong>ducted<br />

before initiati<strong>on</strong> of <strong>and</strong> following 90 days of dosing. The<br />

rats were killed <strong>and</strong> organs weighed. Adrenals, pituitary,<br />

ovaries, <strong>and</strong> thyroid were weighed following fixati<strong>on</strong> in<br />

10% neutral buffered formalin. Histopathological examinati<strong>on</strong>s<br />

were c<strong>on</strong>ducted in tissues from 10 rats/sex/group<br />

in <strong>the</strong> c<strong>on</strong>trol <strong>and</strong> high-dose groups. Organs histologically<br />

examined included prostate, uterus, testis, <strong>and</strong> ovary.<br />

Statistical analyses included w 2 test with Yates correcti<strong>on</strong>,<br />

Fisher exact probability test, Mann–Whitney U-test, ANO­<br />

VA, t-test, <strong>and</strong> Dunnett multiple comparis<strong>on</strong> test.<br />

In parental rats, bisphenol A exposure did not affect<br />

general behavior, appearance, or survival. Mean body<br />

weight of males in <strong>the</strong> 1000 ppm group was 6% lower<br />

than c<strong>on</strong>trol males. Food intake was increased [by B7–<br />

11%, no dose–resp<strong>on</strong>se] in females of all dose groups.<br />

Bisphenol A exposure had no effect <strong>on</strong> estrous cyclicity<br />

or gestati<strong>on</strong> length [data were not shown], male or<br />

female fertility, number of pups/litter, or pup survival<br />

Body weights of pups in <strong>the</strong> 750 ppm group were<br />

significantly higher [by B10%] compared to c<strong>on</strong>trols<br />

<strong>on</strong> PND 21, but <strong>the</strong> study authors did not c<strong>on</strong>sider <strong>the</strong><br />

effect to be treatment-related.<br />

In <strong>the</strong> F 1 offspring, a slight decrease in body weight<br />

gain was observed for males in <strong>the</strong> 750 ppm group. [At<br />

<strong>the</strong> end of <strong>the</strong> study, body weights of males in <strong>the</strong><br />

750 ppm group were B7% less than c<strong>on</strong>trols]. Food<br />

intake was similar in treated <strong>and</strong> c<strong>on</strong>trol groups.<br />

Ophthalmoscope examinati<strong>on</strong>s did not reveal any treatment-related<br />

effects. Although mean blood urea nitrogen<br />

levels were slightly lower <strong>and</strong> mean serum glutamicoxaloacetic<br />

transaminase values were sporadically increased<br />

in treated rats, <strong>the</strong> study authors noted that <strong>the</strong><br />

values were within physiological ranges. There were no<br />

effects <strong>on</strong> hematological or urinalysis parameters. Some<br />

significant organ weight changes were noted by <strong>the</strong><br />

study authors, but <strong>the</strong>y stated that <strong>the</strong> biological<br />

significance of <strong>the</strong> effects was not known. [There did<br />

not appear to be dose–resp<strong>on</strong>se relati<strong>on</strong>ships for any<br />

organ weight change.] The study authors stated that no<br />

compound-related lesi<strong>on</strong>s were observed in organs,<br />

including reproductive organs.<br />

Strengths/Weaknesses: The use of multiple dose levels<br />

(going down to fairly low exposure levels) is a plus, as is a<br />

breeding phase. Weaknesses include <strong>the</strong> limited number of<br />

animals per group, discarding of <strong>the</strong> parental animals<br />

without examinati<strong>on</strong>, <strong>the</strong> fact that not all F1 animals were<br />

examined at least for structural effects, <strong>the</strong> lack of close<br />

examinati<strong>on</strong> of F 1 animals for reproductive effects (cyclicity<br />

<strong>and</strong> sperm measures), <strong>and</strong> <strong>the</strong> use of <strong>the</strong> c<strong>on</strong>venti<strong>on</strong>al ‘‘topdown’’<br />

pathology evaluati<strong>on</strong>, wherein <strong>the</strong> lower dose<br />

groups were examined <strong>on</strong>ly if effects were noted in <strong>the</strong><br />

high-dose. The study has not been peer-reviewed.<br />

Utility (Adequacy) for CERHR Evaluati<strong>on</strong> Process:<br />

For what it is, this study is adequate <strong>and</strong> of limited<br />

utility for <strong>the</strong> evaluative process, showing no gross<br />

changes in <strong>the</strong> structure of a limited number of tissues in<br />

a limited number of F 1 animals, exposed from prec<strong>on</strong>cepti<strong>on</strong>.<br />

This study was not designed to find unusual<br />

effects or n<strong>on</strong>-linear dose–resp<strong>on</strong>se relati<strong>on</strong>ships or to<br />

address <strong>the</strong> issue of low-dose functi<strong>on</strong>al resp<strong>on</strong>ses or<br />

n<strong>on</strong>-linear resp<strong>on</strong>ses.<br />

Ema et al. (2001), supported by <strong>the</strong> Japanese Ministry<br />

of Health <strong>and</strong> Welfare, examined developmental toxicity<br />

Birth Defects Research (Part B) 83:157–395, 2008<br />

BISPHENOL A<br />

249<br />

endpoints, in a 2 generati<strong>on</strong> rats study described in detail<br />

in Secti<strong>on</strong> 4.2.3.1. Two generati<strong>on</strong>s of rats were gavaged<br />

with 0, 0.0002, 0.002, 0.020, or 0.200 mg/kg bw/day<br />

bisphenol A (99.9% purity) before <strong>and</strong> during mating<br />

<strong>and</strong> throughout <strong>the</strong> gestati<strong>on</strong> <strong>and</strong> lactati<strong>on</strong> period. These<br />

doses were based <strong>on</strong> previous studies that found effects<br />

at 0.002 <strong>and</strong> 0.020 mg/kg bw/day. There were some n<strong>on</strong>dose-related<br />

<strong>and</strong> sporadic effects, but <strong>the</strong> study authors<br />

c<strong>on</strong>cluded that n<strong>on</strong>e of <strong>the</strong> effects were related to<br />

bisphenol A treatment. Bisphenol A exposure did not<br />

adversely affect prenatal or postnatal growth or survival,<br />

developmental l<strong>and</strong>marks, anogenital distance, or age of<br />

puberty. In adult animals exposed to bisphenol A during<br />

development, <strong>the</strong>re was no evidence of adverse effects<br />

<strong>on</strong> reproductive endpoints such as fertility, estrous<br />

cyclicity, or sperm counts. Prostate <strong>and</strong> o<strong>the</strong>r male<br />

reproductive organ weights were unaffected.<br />

Strengths/Weaknesses: Strengths of this study were<br />

<strong>the</strong> thoroughness of <strong>the</strong> evaluati<strong>on</strong>, <strong>the</strong> size of <strong>the</strong> dose<br />

range, <strong>the</strong> large number of animals, <strong>the</strong> litter-based<br />

analysis, <strong>and</strong> <strong>the</strong> verificati<strong>on</strong> of <strong>the</strong> dosing soluti<strong>on</strong>. A<br />

minor weakness is <strong>the</strong> lack of a positive c<strong>on</strong>trol group,<br />

which leaves a questi<strong>on</strong> about <strong>the</strong> ability of this group of<br />

rats to resp<strong>on</strong>d.<br />

Utility (Adequacy) for CERHR Evaluati<strong>on</strong> Process:<br />

This study is adequate <strong>and</strong> of high utility for <strong>the</strong><br />

evaluati<strong>on</strong> process.<br />

Tyl et al. (2002b), supported by The Society of <strong>the</strong><br />

Plastics Industry, Inc., reported some developmental<br />

toxicity effects in a multigenerati<strong>on</strong> bisphenol A study<br />

in Sprague–Dawley rats that is reported in detail in<br />

Secti<strong>on</strong> 4.2.3.1. In that study, F 1, F2, <strong>and</strong> F3 rats were<br />

exposed to bisphenol A [99.70%-99.76% pure] indirectly<br />

during gestati<strong>on</strong> <strong>and</strong> lactati<strong>on</strong> <strong>and</strong> directly through feed<br />

after weaning. Dietary doses were 0, 0.015, 0.3, 4.5, 75,<br />

750, or 7500 ppm, <strong>and</strong> target intakes were B0.001, 0.02,<br />

0.30, 5, 50, <strong>and</strong> 500 mg/kg bw/day. At <strong>the</strong> 7500 ppm dose<br />

<strong>the</strong>re were fewer pups <strong>and</strong> live pups/litter <strong>and</strong> body<br />

weight gain of pups was lower during <strong>the</strong> lactati<strong>on</strong><br />

period. Delayed puberty in both males <strong>and</strong> females of <strong>the</strong><br />

7500 ppm group was most likely related to reduced body<br />

weights according to <strong>the</strong> study authors. Bisphenol A<br />

exposure during development did not increase <strong>the</strong><br />

weight of <strong>the</strong> prostate in adult rats. Although some<br />

decreases in epididymal sperm c<strong>on</strong>centrati<strong>on</strong> <strong>and</strong><br />

daily sperm endpoints were each observed in 1 generati<strong>on</strong><br />

of males from <strong>the</strong> high-dose group, <strong>the</strong> study authors<br />

c<strong>on</strong>cluded <strong>the</strong>re were no treatment-related effects <strong>on</strong><br />

sperm endpoints or reproductive functi<strong>on</strong>. The study<br />

authors identified an offspring <strong>and</strong> reproductive NOAEL<br />

of 750 ppm (B50 mg/kg bw/day). A systemic NOAEL<br />

for adult rats was identified at 75 ppm (B5 mg/kg bw/<br />

day) by <strong>the</strong> study authors; <strong>the</strong>refore, bisphenol A was not<br />

c<strong>on</strong>sidered a selective developmental toxicant.<br />

Strengths/Weaknesses: This study has numerous<br />

strengths, including <strong>the</strong> quality <strong>and</strong> number of <strong>the</strong><br />

endpoints evaluated, <strong>the</strong> number of dose groups <strong>and</strong><br />

generati<strong>on</strong>s examined, <strong>and</strong> <strong>the</strong> c<strong>on</strong>firmati<strong>on</strong> of dosing<br />

soluti<strong>on</strong>s. This study incorporated screening-level endpoints<br />

within <strong>the</strong> c<strong>on</strong>text of a multigenerati<strong>on</strong> study. As<br />

such, it addresses gross issues but does provide helpful<br />

data regarding <strong>the</strong> NOAEL.<br />

Utility (Adequacy) for CERHR Evaluati<strong>on</strong> Process:<br />

This study is adequate <strong>and</strong> of high utility for <strong>the</strong><br />

evaluati<strong>on</strong> process.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!